The facilities will be built in West Columbia’s Saxe-Gotha Industrial Park, according to a July 9 news release from the drugmaker. Its construction of a large-scale vaccination manufacturing facility suggests it could soon partner with other pharma companies developing COVID-19 vaccine candidates.
Nephron, one of the country’s fastest-growing drugmakers, manufactures generic drugs, many of which treat respiratory problems that can arise from COVID-19.
More articles on pharmacy:
CVS Health launches campaign to encourage primary care during pandemic
Teva to serve as defendant in bellwether trial alleging generic drug price-fixing
Dozens of patents protect AbbVie’s pricey cancer drug against competition, report finds
